Martin Van Trieste, BPharm, is the President and CEO of Civica Rx, which is a non-profit company whose mission is to ensure that essential generic medications are accessible and affordable. 

Civica Rx has partnered with health systems to reduce drug shortages and recently announced they will begin manufacturing insulin for release in 2024 that will cost no more than $30 per vial and no more than $55/box of 5 pen cartridges. Martin has been named one of the 100 most influential people in healthcare!

https://civicarx.org